Roto-Rooter paid about $62.5 million for California territories covering over 12 million residents.
Chemed Corporation (CHEM) reported Q3 2026 revenue of $690.9M, up 10.6%. VITAS Healthcare saw revenue increase 12.2% to $457.4M, while Roto-Rooter revenue rose 7.5% to $233.5M. The company reacquired California territories for $62.5M and expects to meet or exceed adjusted EPS guidance.
How this was made
The 30-second read
Why it matters
The earnings release provides fresh data on revenue growth and profitability, influencing investor sentiment.
Market read
First‑time Q3 earnings disclosure with material financial improvements, offering a clear trading signal.
What to watch
Potential headwinds from Medicare cap adjustments and franchise integration costs could temper upside.
Background
Chemed Corporation operates VITAS hospice services and Roto‑Rooter plumbing services, reporting its third‑quarter financials.
Ticker impact
Chemed reported Q3 2026 results with revenue up 10.6% to $690.9M, GAAP EPS $5.45 and adjusted EPS $6.75, beating prior expectations.
likely modest upside as the market prices in better-than-expected earnings
Revenue and EPS both rose significantly year‑over‑year, indicating improved operating performance.
Market effects
Healthcare services and residential/commercial plumbing sectors may see increased investor interest.
U.S. markets may see a modest lift in healthcare and consumer services stocks.
Limited to U.S. investors; no immediate global macro effect.
Counterpoint
If the market had already priced in strong Q3 performance, the stock could face a short‑term pullback.
Key entities
- companyChemed Corporation
Parent company of VITAS Healthcare and Roto‑Rooter.
